Increased liver AGEs induce hepatic injury mediated through an OST48 pathwayAowen Zhuang, Josephine M. Forbes, Felicia Y. T. Yap et al.|Scientific Reports|2017Cited by 33
Five‐year efficacy and safety of tenofovir‐based salvage therapy for patients with chronic hepatitis B who previously failed <scp>LAM</scp>/<scp>ADV</scp> therapyLucy Lim, Peter Angus, Simone I. Strasser et al.|Liver International|2016Cited by 14